Back to Authors

By, Kunthel

A5004023242

Mayo Clinic

BeiGene USA, Inc San Mateo California USA

Citations 2

147 | UPDATED EFFICACY & SAFETY OF BTK DEGRADER BGB‐16673 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (R/R WM): ONGOING PHASE 1 CaDAnCe‐101 RESULTS

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70093_147

144 | UPDATED EFFICACY/SAFETY OF THE BRUTON TYROSINE KINASE (BTK) DEGRADER BGB‐16673 IN RELAPSED/REFRACTORY (R/R) CLL/SLL: RESULTS FROM THE ONGOING PHASE 1 CaDAnCe‐101 STUDY

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70093_144